Phase Ib Trial of Two Folate Binding Protein Peptide Vaccines (E39 and J65) in Breast and Ovarian Cancer Patients
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Ovarian Cancer
Interventions: BIOLOGICAL: E39 peptide vaccine|BIOLOGICAL: E39 vaccine then J65 vaccine|BIOLOGICAL: J65 vaccine then E39 vaccine
Sponsor: COL George Peoples, MD, FACS
Collaborators: M.D. Anderson Cancer Center